ABT logo Abbott Laboratories +
Abbott Laboratories
+

Abbott Laboratories (ABT) Business News

Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
10:00 AM | Saturday | Jun 6, 2026 GuruFocus

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

News Thumbnail
9:00 AM | Saturday | Jun 6, 2026 PRNewsWire

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

News Thumbnail
9:00 AM | Saturday | Jun 6, 2026 PRNewsWire

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

News Thumbnail
11:02 AM | Thursday | Jun 4, 2026 Zacks Investment Research

Abbott Addresses a Major Diabetes Care Gap With Tech Innovation

News Thumbnail
7:04 AM | Tuesday | Jun 2, 2026 GuruFocus

ABT DCF Analysis: Intrinsic Value $93 vs Price $88

News Thumbnail
4:15 AM | Tuesday | Jun 2, 2026 Fool - Investing News

3 Beaten-Down Stocks to Buy and Hold Forever

News Thumbnail
10:56 AM | Monday | Jun 1, 2026 Zacks Investment Research

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

News Thumbnail
10:16 AM | Friday | May 29, 2026 Zacks Investment Research

BSX vs. ABT: Which Medical Stock Has More Upside Potential?

News Thumbnail
10:01 AM | Friday | May 29, 2026 Zacks Investment Research

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

News Thumbnail
10:31 AM | Thursday | May 28, 2026 Zacks Investment Research

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

News Thumbnail
9:53 AM | Wednesday | May 27, 2026 Zacks Investment Research

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

News Thumbnail
9:00 AM | Wednesday | May 27, 2026 PRNewsWire

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

News Thumbnail

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

GuruFocus

10:00 AM | Saturday | Jun 6, 2026

news photo
Loading...

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PR Newswire A

Read full article redirect
10:00 AM | Saturday | Jun 6, 2026

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

GuruFocus

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PR Newswire A

Read full article arrow
News Thumbnail
9:00 AM | Saturday | Jun 6, 2026

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

PRNewsWire

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect early Ketone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and delays in intervention Nearly 60% of pediatric hospitalizations for Type 1 diabetes in the U.S. are associated with DKA1 ABBOTT PARK, Ill., June 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected health concern for people living with both Type 1 and Type 2 diabetes.

Read full article arrow
News Thumbnail
9:00 AM | Saturday | Jun 6, 2026

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

PRNewsWire

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect early Ketone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and delays in intervention Nearly 60% of pediatric hospitalizations for Type 1 diabetes in the U.S. are associated with DKA1 ABBOTT PARK, Ill., June 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected health concern for people living with both Type 1 and Type 2 diabetes.

Read full article arrow
News Thumbnail
11:02 AM | Thursday | Jun 4, 2026

Abbott Addresses a Major Diabetes Care Gap With Tech Innovation

Zacks Investment Research

ABT wins the CE Mark for Libre Duo sensors that track glucose and ketones every minute, aiming to spot DKA risks earlier and reduce routine testing.

Read full article arrow
News Thumbnail
7:04 AM | Tuesday | Jun 2, 2026

ABT DCF Analysis: Intrinsic Value $93 vs Price $88

GuruFocus

On June 02, 2026, we take a closer look at the DCF analysis for Abbott Laboratories (ABT). The stock has experienced notable price performance, with a year-to-d

Read full article arrow
News Thumbnail
4:15 AM | Tuesday | Jun 2, 2026

3 Beaten-Down Stocks to Buy and Hold Forever

Fool - Investing News

Don't wait too long to buy the dip on these stocks.

Read full article arrow
News Thumbnail
10:56 AM | Monday | Jun 1, 2026

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

Zacks Investment Research

ABT wins CE Mark for Libre Duo systems, the first dual glucose-ketone sensors, enabling real-time monitoring as European rollout begins later this year.

Read full article arrow
News Thumbnail
10:16 AM | Friday | May 29, 2026

BSX vs. ABT: Which Medical Stock Has More Upside Potential?

Zacks Investment Research

Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.

Read full article arrow
News Thumbnail
10:01 AM | Friday | May 29, 2026

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Zacks Investment Research

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Read full article arrow
News Thumbnail
10:31 AM | Thursday | May 28, 2026

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

Zacks Investment Research

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Read full article arrow
News Thumbnail
9:53 AM | Wednesday | May 27, 2026

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

Zacks Investment Research

ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.

Read full article arrow
News Thumbnail
9:00 AM | Wednesday | May 27, 2026

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

PRNewsWire

First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to diabetic ketoacidosis, a serious health condition for people with diabetes Integrates with the Libre digital health ecosystem, allowing people to share glucose and ketone data with caregivers and healthcare providers Designed for compatibility with leading automated insulin delivery (AID) systems ABBOTT PARK, Ill., May 27, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual glucose‑ketone sensing technology for people with diabetes.

Read full article arrow
News Thumbnail